193 related articles for article (PubMed ID: 9539970)
1. In vivo mutagenesis by the hepatocarcinogen quinoline in the lacZ transgenic mouse: evidence for its in vivo genotoxicity.
Suzuki T; Miyata Y; Saeki K; Kawazoe Y; Hayashi M; Sofuni T
Mutat Res; 1998 Jan; 412(2):161-6. PubMed ID: 9539970
[TBL] [Abstract][Full Text] [Related]
2. Antimutagenic structural modification of quinoline assessed by an in vivo mutagenesis assay using lacZ-transgenic mice.
Miyata Y; Saeki K; Kawazoe Y; Hayashi M; Sofuni T; Suzuki T
Mutat Res; 1998 May; 414(1-3):165-9. PubMed ID: 9630605
[TBL] [Abstract][Full Text] [Related]
3. Nitrogen-substitution effect on in vivo mutagenicity of chrysene.
Yamada K; Suzuki T; Kohara A; Kato TA; Hayashi M; Mizutani T; Saeki K
Mutat Res; 2005 Sep; 586(1):1-17. PubMed ID: 16054434
[TBL] [Abstract][Full Text] [Related]
4. In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta mice and c-myc/lacZ double transgenic mice.
Davis CD; Dacquel EJ; Schut HA; Thorgeirsson SS; Snyderwine EG
Mutat Res; 1996 Sep; 356(2):287-96. PubMed ID: 8841498
[TBL] [Abstract][Full Text] [Related]
5. In vivo mutagenicity of benzo[f]quinoline, benzo[h]quinoline, and 1,7-phenanthroline using the lacZ transgenic mice.
Yamada K; Suzuki T; Kohara A; Hayashi M; Mizutani T; Saeki K
Mutat Res; 2004 Apr; 559(1-2):83-95. PubMed ID: 15066577
[TBL] [Abstract][Full Text] [Related]
6. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
Hayward JJ; Shane BS; Tindall KR; Cunningham ML
Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
[TBL] [Abstract][Full Text] [Related]
7. The concomitant detection of gene mutation and micronucleus induction by mitomycin C in vivo using lacZ transgenic mice.
Suzuki T; Hayashi M; Sofuni T; Myhr BC
Mutat Res; 1993 Feb; 285(2):219-24. PubMed ID: 7678894
[TBL] [Abstract][Full Text] [Related]
8. Dinitropyrenes induce gene mutations in multiple organs of the lambda/lacZ transgenic mouse (Muta Mouse).
Kohara A; Suzuki T; Honma M; Oomori T; Ohwada T; Hayashi M
Mutat Res; 2002 Mar; 515(1-2):73-83. PubMed ID: 11909756
[TBL] [Abstract][Full Text] [Related]
9. [Anti-carcinogenic structural modification by fluorine-substitution in aza-polycyclic aromatic hydrocarbons].
Saeki K
Yakugaku Zasshi; 2000 Dec; 120(12):1373-85. PubMed ID: 11193386
[TBL] [Abstract][Full Text] [Related]
10. Genotoxicity of o-aminoazotoluene (AAT) determined by the Ames test, the in vitro chromosomal aberration test, and the transgenic mouse gene mutation assay.
Ohsawa K; Hirano N; Sugiura M; Nakagawa S; Kimura M
Mutat Res; 2000 Nov; 471(1-2):113-26. PubMed ID: 11080667
[TBL] [Abstract][Full Text] [Related]
11. Hepatocarcinogen quinoline induces G:C to C:G transversions in the cII gene in the liver of lambda/lacZ transgenic mice (MutaMouse).
Suzuki T; Wang X; Miyata Y; Saeki K; Kohara A; Kawazoe Y; Hayashi M; Sofuni T
Mutat Res; 2000 Nov; 456(1-2):73-81. PubMed ID: 11087898
[TBL] [Abstract][Full Text] [Related]
12. Induction of LacZ mutations in Muta Mouse can distinguish carcinogenic from non-carcinogenic analogues of diaminotoluenes and nitronaphthalenes.
Kirkland D; Beevers C
Mutat Res; 2006 Sep; 608(1):88-96. PubMed ID: 16797226
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta Mouse and Big Blue transgenic mice.
Lefevre PA; Tinwell H; Galloway SM; Hill R; Mackay JM; Elcombe CR; Foster J; Randall V; Callander RD; Ashby J
Hum Exp Toxicol; 1994 Nov; 13(11):764-75. PubMed ID: 7857696
[TBL] [Abstract][Full Text] [Related]
14. Procarbazine genotoxicity in the MutaMouse; strong clastogenicity and organ-specific induction of lacZ mutations.
Suzuki T; Uno Y; Idehara K; Baba T; Maniwa J; Ohkouchi A; Wang X; Hayashi M; Sofuni T; Tsuruoka M; Miyajima H; Kondo K
Mutat Res; 1999 Aug; 444(2):269-81. PubMed ID: 10521668
[TBL] [Abstract][Full Text] [Related]
15. DNA adducts and mutagenic specificity of the ubiquitous environmental pollutant 3-nitrobenzanthrone in Muta Mouse.
Arlt VM; Zhan L; Schmeiser HH; Honma M; Hayashi M; Phillips DH; Suzuki T
Environ Mol Mutagen; 2004; 43(3):186-95. PubMed ID: 15065206
[TBL] [Abstract][Full Text] [Related]
16. Mutation studies with dimethyl nitrosamine in young and old lac I transgenic mice.
Tinwell H; Lefevre PA; Ashby J
Mutat Res; 1994 Jun; 307(2):501-8. PubMed ID: 7514724
[TBL] [Abstract][Full Text] [Related]
17. Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.
Cunningham ML; Hayward JJ; Shane BS; Tindall KR
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):683-6. PubMed ID: 8781405
[TBL] [Abstract][Full Text] [Related]
18. Initial experiences and future directions for transgenic mouse mutation assays.
Suzuki T; Hayashi M; Sofuni T
Mutat Res; 1994 Jun; 307(2):489-94. PubMed ID: 7514722
[TBL] [Abstract][Full Text] [Related]
19. Repeated-dose liver and gastrointestinal tract micronucleus assays for quinoline in rats.
Uno F; Tanaka J; Ueda M; Nagai M; Fukumuro M; Natsume M; Oba M; Akahori A; Masumori S; Takami S; Wako Y; Kawasako K; Kougo Y; Ohyama W; Narumi K; Fujiishi Y; Okada E; Hayashi M
Mutat Res Genet Toxicol Environ Mutagen; 2015 Mar; 780-781():51-5. PubMed ID: 25892622
[TBL] [Abstract][Full Text] [Related]
20. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
